A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets

NCT04481607 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor or Hematologic Tumor

Interventions

DRUG: TQB3454

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.